BRIEF-Eli Lilly Phase 2 Data Showed Eloratzp Delivered Weight Loss Of Up To Average Of 54.1 Lbs (23.3%) At 48 Weeks In Adults With Obesity, Type 2 Diabetes

0

Nov 14 (Reuters) – Eli Lilly and Company: * ELI LILLY: PHASE 2 DATA SHOWED ELORATZP DELIVERED WEIGHT LOSS OF UP TO AVERAGE OF 54.1 LBS (23.3%) AT 48 WEEKS IN ADULTS WITH OBESITY, TYPE 2 DIABETES * ELI

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)